- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
Patent holdings for IPC class A61K 47/64
Total number of patents in this class: 4970
10-year publication summary
91
|
199
|
311
|
563
|
650
|
724
|
696
|
788
|
709
|
192
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
81 |
Glaxosmithkline Biologicals S.A. | 1701 |
58 |
Bicyclerd Limited | 130 |
58 |
Mayo Foundation for Medical Education and Research | 2981 |
57 |
Sarepta Therapeutics, Inc. | 353 |
48 |
Massachusetts Institute of Technology | 9795 |
44 |
Yale University | 2204 |
40 |
Pfizer Inc. | 3322 |
39 |
Purdue Research Foundation | 3277 |
39 |
Bicycletx Limited | 149 |
38 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
34 |
Bristol-myers Squibb Company | 5080 |
33 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
32 |
Sapreme Technologies B.V. | 74 |
30 |
Northwestern University | 3112 |
27 |
The Johns Hopkins University | 5377 |
26 |
President and Fellows of Harvard College | 5792 |
26 |
Ohio State Innovation Foundation | 1770 |
25 |
Board of Regents, The University of Texas System | 5370 |
22 |
Case Western Reserve University | 1727 |
21 |
Other owners | 4192 |